🔗 Visit the ClinicalTrials.gov page for NCT01334710
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. | Oncotarget | 2012 | 1.55 |
| 2 | Clinical trials in hepatocellular carcinoma: an update. | Liver Cancer | 2013 | 0.99 |
| 3 | Targeting the insulin-like growth factor pathway in hepatocellular carcinoma. | World J Hepatol | 2014 | 0.87 |
| 4 | Targeted therapies in the treatment of advanced hepatocellular carcinoma. | Clin Med Insights Oncol | 2013 | 0.83 |
| 5 | The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets. | Infect Agent Cancer | 2014 | 0.78 |